|
Delayed
Nasdaq
11:01:31 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 6.815 USD | +1.11% |
|
+5.36% | -11.14% |
| 25-06-16 | Crescent Biopharma Completes Merger With GlycoMimetics | MT |
| 23-10-30 | Catalyst Biosciences, Inc.(NasdaqCM:CBIO) dropped from NASDAQ Composite Index | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
- Stock Market
- Stocks
- CBIO Stock
- Charts Catalyst Biosciences
- Total Return chart
Select your edition
All financial news and data tailored to specific country editions
